Vaxart reports inducement grants under Nasdaq listing rule

Vaxart announced that the Compensation Committee of the Board of Directors approved certain equity awards to the Company’s new President and Chief Executive Officer, Steven Lo, effective March 18, 2024. The awards were made pursuant to the Company’s previously disclosed offer letter with Lo, and as a material inducement to his joining the Company as President and Chief Executive Officer and a member of the Board of Directors. The awards made to Mr. Lo are as follows: an option to purchase 1,000,000 shares of Vaxart’s common stock, which vests as to 1/4th of the total shares on the one-year anniversary of his start date, and as to 1/48th of the total shares on each month thereafter, and has a per share exercise price equal to the closing price of Vaxart’s common stock on the grant date; and a restricted stock unit award covering 250,000 shares of Vaxart’s common stock, which vests as to 25% of the shares underlying the award on the first, second, third and fourth anniversary of his start date. The awards were granted under the Vaxart, Inc. 2024 Inducement Award Plan as an employment “inducement award” pursuant to Nasdaq Listing Rule 5635(c)(4).